Author:
Steele Ethan M.,Burney Heather N.,Freije Samantha L.,Zellars Richard C.,Lautenschlaeger Tim,Holmes Jordan A.
Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2022. CA Cancer J. Clin. 72(1), 7–33. https://doi.org/10.3322/caac.21708 (2022).
2. The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 365(5), 395–408. https://doi.org/10.1056/NEJMoa1102873 (2011).
3. National Comprehensive Cancer Network. Small Cell Lung Cancer NCCN Evidence Blocks. Accessed March 10, 2019. https://www.nccn.org/professionals/physician_gls/pdf/sclc_blocks.pdf (2018).
4. National Comprehensive Cancer Network. Non-Small Cell Lung Cancer NCCN Evidence Blocks. Accessed March 10, 2019. https://www.nccn.org/professionals/physician_gls/pdf/nscl_blocks.pdf (2019).
5. Carr, S. R. et al. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system. J. Thorac. Cardiovasc. Surg. 143, 390–397. https://doi.org/10.1016/j.jtcvs.2011.10.023 (2012).